Here are the top health stories for the day:
NExT exam for 2020 MBBS batch: Health Ministry forms committee to examine preparedness of medical colleges
In a new development on the National Exit Test (NExT), the Health Ministry has constituted a seven-member committee to look into the preparedness of states and medical colleges for the implementation of the exam for final year MBBS students of the 2020 batch.
According to a recent report by PTI, the health ministry said in an order issued on Tuesday, "It has been decided to constitute a committee with approval of the Ministry for Health and Family Welfare Mansukh Mandaviya to examine the implementation and preparedness for NExT."
For more details, check out the link given below:
Drug Safety Alert: Indian Pharmacopoeia Commission flags ADR linked to GERD drug Esomeprazole
The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of September, has revealed that Esomeprazole, indicated for the treatment of Gastroesophageal reflux disease (GERD), is linked with adverse drug reactions (ADRs) named Hyperprolactinaemia.
In connection to the above, the Indian Pharmacopoeia Commission (IPC) has cautioned healthcare professionals to diligently monitor the potential occurrence of Adverse Drug Reactions (ADRs) when administering Esomeprazole.
For more details, check out the link given below:
Drug Safety Alert: Indian Pharmacopoeia Commission Flags ADR Linked To GERD Drug Esomeprazole
Roche Diagnostics names Rishubh Gupta as MD for India, neighbouring markets
Roche Diagnostics India has said it has appointed Rishubh Gupta as its new Managing Director for India and neighbouring markets.
Gupta will lead and oversee the company's operations, strategy, and growth initiatives in India, Bangladesh, Bhutan, Nepal and Sri Lanka.
"His proven track record in healthcare leadership, coupled with his passion for innovation, aligns perfectly with our commitment to advancing diagnostics for better patient care in India," Roche APAC Sub-Region 1 Head Thilo Brenner said in a statement.
For more details, check out the link given below:
Roche Diagnostics Ropes In Rishubh Gupta As New MD For India, Neighbouring Markets
CDC recommends common antibiotic as a 'Morning-After' STI Prevention
The U.S. Centers for Disease Control and Prevention (CDC) is preparing to suggest the use of a potent antibiotic for preventing sexually transmitted infections (STIs). The CDC recently released preliminary guidelines, advising healthcare professionals to consider prescribing doxycycline as a preventive measure against the spread of these infections.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.